- Home
- GENK vs NXPL Comparison
GENK vs NXPL Comparison
Compare GENK & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENK
- NXPL
- Stock Information
- Founded
- GENK 2011
- NXPL 1997
- Country
- GENK United States
- NXPL United States
- Employees
- GENK N/A
- NXPL N/A
- Industry
- GENK Restaurants
- NXPL Telecommunications Equipment
- Sector
- GENK Consumer Discretionary
- NXPL Telecommunications
- Exchange
- GENK Nasdaq
- NXPL Nasdaq
- Market Cap
- GENK 27.9M
- NXPL 32.5M
- IPO Year
- GENK 2023
- NXPL N/A
- Fundamental
- Price
- GENK $5.65
- NXPL $1.01
- Analyst Decision
- GENK Strong Buy
- NXPL
- Analyst Count
- GENK 3
- NXPL 0
- Target Price
- GENK $12.17
- NXPL N/A
- AVG Volume (30 Days)
- GENK 206.0K
- NXPL 45.7K
- Earning Date
- GENK 03-06-2025
- NXPL 03-17-2025
- Dividend Yield
- GENK N/A
- NXPL N/A
- EPS Growth
- GENK 62.05
- NXPL N/A
- EPS
- GENK 0.13
- NXPL N/A
- Revenue
- GENK $208,380,000.00
- NXPL $66,482,000.00
- Revenue This Year
- GENK $20.99
- NXPL N/A
- Revenue Next Year
- GENK N/A
- NXPL N/A
- P/E Ratio
- GENK $44.87
- NXPL N/A
- Revenue Growth
- GENK 15.12
- NXPL 179.89
- 52 Week Low
- GENK $5.00
- NXPL $0.71
- 52 Week High
- GENK $14.46
- NXPL $2.68
- Technical
- Relative Strength Index (RSI)
- GENK 47.16
- NXPL 52.18
- Support Level
- GENK $5.30
- NXPL $0.84
- Resistance Level
- GENK $7.41
- NXPL $0.99
- Average True Range (ATR)
- GENK 0.59
- NXPL 0.08
- MACD
- GENK 0.08
- NXPL 0.01
- Stochastic Oscillator
- GENK 26.97
- NXPL 86.69
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc is an Asian casual dining restaurant in the United States. It offers an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables.
About NXPL NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.